Influx Healthtech share news, announcements and annual reports
NSE: INFLUXPharmaceuticals & Biotechnology
Share price at the NSE close on 28 Oct 2026. Previous close ₹253.85.
28 Oct: open ₹259.95, high ₹274.95, low ₹259.05
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹625 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 30.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 6.20
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 20.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 25,20095.2% delivered
Influx Healthtech has 58 announcements on record, routine notices left out; 1 in the 30 days to 29 Oct 2026, the latest on 28 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Influx Healthtech half-yearly results
The board meets on 4 Nov 2026 to consider financial results
Notice filed 28 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Influx Healthtech annual reports, presentations and earnings calls
The company's own documents, latest first.Influx Healthtech financials, year by year
Annual reports2
- Annual report, year to Mar 202626 Aug 2026
- Annual report, year to Mar 202514 Aug 2025
Investor presentations3
- Investor Presentation21 May 2026
- Investor Presentation12 Nov 2025
- Presentation22 Aug 2025
Earnings calls4
- Transcript of Investor Conference Call held on May 22, 202626 May 2026
- Link of Audio Recording of Investor Conference call held on May 22, 202622 May 2026
- Transcript of Analyst/Institutional Investor Earnings call held on November 12, 202518 Nov 2025
- Link of Audio Recording of the Analyst/Institutional Investor Earnings Call Meet12 Nov 2025
Influx Healthtech share news and announcements
Newest first. Page 1 of 2.
Oct 2026
28 Oct · Board meeting
Sep 2026
24 Sep · General Updates
23 Sep · Analysts
18 Sep · Meeting
Aug 2026
26 Aug · Board meeting
Jul 2026
10 Jul · Updates
Jun 2026
May 2026
20 May · Results
14 May · Analysts
13 May · Board meeting
Apr 2026
21 Apr · Updates
6 Apr · Corrigendum
1 Apr · Meeting
Mar 2026
31 Mar · Board meeting
18 Mar · Management
5 Mar · Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
5 Mar · Analysts
Feb 2026
27 Feb · Analysts
24 Feb · Analysts
4 Feb · Incorporation
Jan 2026
6 Jan · Analysts
1 Jan · Analysts
Dec 2025
16 Dec · Analysts
5 Dec · Analysts
3 Dec · Analysts
1 Dec · Analysts
Nov 2025
18 Nov · Business
4 Nov · Analysts
Oct 2025
29 Oct · Board meeting
16 Oct · Business
Sep 2025
15 Sep · Analysts
12 Sep · Analysts
9 Sep · Analysts
3 Sep · Analysts
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 21 May 2026Resultsdown 16.50%−16.6 pts vs Nifty 500market median −0.7% · five sessions −16.8% (−18.5 pts vs Nifty 500) · volume 10.5× usual · The announcement
- 19 Mar 2026Board or managers changeddown 4.86%−1.7 pts vs Nifty 500market median 0.0% · five sessions −0.4% (+1.6 pts vs Nifty 500) · volume 0.8× usual · The announcement
- 12 Nov 2025Resultsup 4.98%+4.3 pts vs Nifty 500market median −0.7% · five sessions +21.5% (+20.9 pts vs Nifty 500) · volume 4.6× usual · The announcement
Influx Healthtech results filing dates and deadlines
Listed companies must file half-yearly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Dealing with a related party in the period | Year to date to Sep 2025 | Standalone | 4,84,893.21 | 4.85 | −100.0% | 12 Nov 2025 | 3 Jan 2026 |